BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25246047)

  • 21. Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging.
    Krüger S; Mottaghy FM; Buck AK; Maschke S; Kley H; Frechen D; Wibmer T; Reske SN; Pauls S
    Nuklearmedizin; 2011; 50(3):101-6. PubMed ID: 21165538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the best way to diagnose and stage malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging of mesothelioma.
    Gill RR
    Recent Results Cancer Res; 2011; 189():27-43. PubMed ID: 21479894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications.
    Lee KS; Jeong YJ; Han J; Kim BT; Kim H; Kwon OJ
    Radiographics; 2004; 24(6):1617-36; discussion 1632-6. PubMed ID: 15537972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
    Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
    Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
    Wang ZJ; Reddy GP; Gotway MB; Higgins CB; Jablons DM; Ramaswamy M; Hawkins RA; Webb WR
    Radiographics; 2004; 24(1):105-19. PubMed ID: 14730040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New applications of magnetic resonance imaging for thoracic oncology.
    Ohno Y
    Semin Respir Crit Care Med; 2014 Feb; 35(1):27-40. PubMed ID: 24481757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of imaging in diagnosis, staging and follow-up of lung cancer.
    De Wever W; Verschakelen J; Coolen J
    Curr Opin Pulm Med; 2014 Jul; 20(4):385-92. PubMed ID: 24837705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET/MRI and PET/CT in Lung Lesions and Thoracic Malignancies.
    Flechsig P; Mehndiratta A; Haberkorn U; Kratochwil C; Giesel FL
    Semin Nucl Med; 2015 Jul; 45(4):268-81. PubMed ID: 26050655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal imaging protocols for lung cancer staging: CT, PET, MR imaging, and the role of imaging.
    Paul NS; Ley S; Metser U
    Radiol Clin North Am; 2012 Sep; 50(5):935-49. PubMed ID: 22974779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant pleural mesothelioma: utility of 18 F-FDG PET.
    Spitilli MG; Treglia G; Calcagni ML; Giordano A
    Ann Ital Chir; 2007; 78(5):393-6. PubMed ID: 18338546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET scan contribution in chest tumor management: a systematic review for thoracic surgeons.
    Duranti L; Leo F; Pastorino U
    Tumori; 2012; 98(2):175-84. PubMed ID: 22677982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation-induced myositis mimicking chest wall tumor invasion in two patients with lung cancer: a PET/CT study.
    Tomita H; Kita T; Hayashi K; Kosuda S
    Clin Nucl Med; 2012 Feb; 37(2):168-9. PubMed ID: 22228342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution and limits of x-ray computed tomography and magnetic resonance imaging in evaluating the extent of primary cancers of the bronchi].
    Laurent F; Drouillard J; Dorcier F; de Verbizier G; Barat JL; Tavernier J
    Bull Cancer; 1988; 75(9):903-16. PubMed ID: 3207896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of multimodality imaging in anaplastic thyroid carcinoma.
    Poppe K; Lahoutte T; Everaert H; Bossuyt A; Velkeniers B
    Thyroid; 2004 Nov; 14(11):981-2. PubMed ID: 15671780
    [No Abstract]   [Full Text] [Related]  

  • 39. 18F-FDG PET-CT features of primary primitive neuroectodermal tumor of the chest wall.
    Demir MK; Koşar F; Sanli Y; Esmaeilzadeh S; Urer HN
    Diagn Interv Radiol; 2009 Sep; 15(3):172-5. PubMed ID: 19728261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid sarcoma presenting as an anterior mediastinal mass invading the pericardium: Serial Imaging With F-18 FDG PET/CT.
    Makis W; Hickeson M; Derbekyan V
    Clin Nucl Med; 2010 Sep; 35(9):706-9. PubMed ID: 20706048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.